|
|
|
|
| LEADER |
04981nam a2200769 4500 |
| 001 |
ocn739118473 |
| 003 |
OCoLC |
| 005 |
20170124071055.8 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
110706s2011 njua ob 001 0 eng d |
| 010 |
|
|
|z 2010048282
|
| 040 |
|
|
|a DG1
|b eng
|e pn
|c DG1
|d CDX
|d E7B
|d N$T
|d OCLCQ
|d YDXCP
|d OCLCQ
|d MYG
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCF
|d OCLCA
|d OCLCQ
|d NLGGC
|d TEFOD
|d DEBSZ
|d MHW
|d IDEBK
|d UKDOC
|d K6U
|d DEBBG
|d TEFOD
|d OCLCQ
|d EBLCP
|d OCLCQ
|d NKT
|d OCLCQ
|d D6H
|d AZK
|d GrThAP
|
| 019 |
|
|
|a 746598433
|a 747412436
|a 747545802
|a 769950588
|a 811493909
|a 816850645
|a 832584725
|a 961547718
|a 962639106
|
| 020 |
|
|
|a 9781118023648
|q (electronic bk.)
|
| 020 |
|
|
|a 1118023641
|q (electronic bk.)
|
| 020 |
|
|
|a 9781118023624
|q (electronic bk.)
|
| 020 |
|
|
|a 1118023625
|q (electronic bk.)
|
| 020 |
|
|
|a 9781118023631
|q (electronic bk.)
|
| 020 |
|
|
|a 1118023633
|q (electronic bk.)
|
| 020 |
|
|
|z 9780470256374
|q (Cloth)
|
| 020 |
|
|
|z 0470256370
|q (Cloth)
|
| 024 |
8 |
|
|a 9786613175656
|
| 029 |
1 |
|
|a AU@
|b 000047774163
|
| 029 |
1 |
|
|a AU@
|b 000053280043
|
| 029 |
1 |
|
|a DEBBG
|b BV041911508
|
| 029 |
1 |
|
|a DEBSZ
|b 430992041
|
| 029 |
1 |
|
|a DKDLA
|b 820120-katalog:000571991
|
| 029 |
1 |
|
|a NLGGC
|b 337107459
|
| 029 |
1 |
|
|a DEBBG
|b BV043393274
|
| 035 |
|
|
|a (OCoLC)739118473
|z (OCoLC)746598433
|z (OCoLC)747412436
|z (OCoLC)747545802
|z (OCoLC)769950588
|z (OCoLC)811493909
|z (OCoLC)816850645
|z (OCoLC)832584725
|z (OCoLC)961547718
|z (OCoLC)962639106
|
| 037 |
|
|
|a 10.1002/9781118023648
|b Wiley InterScience
|n http://www3.interscience.wiley.com
|
| 037 |
|
|
|a E7E4375E-C1F9-4065-A07F-245F67847567
|b OverDrive, Inc.
|n http://www.overdrive.com
|
| 050 |
|
4 |
|a QR189
|b .D48 2011
|
| 060 |
|
4 |
|a QW 805
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615/.372
|2 22
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Development of Vaccines :
|b From Discovery to Clinical Testing /
|c edited by Manmohan Singh, Indresh K. Srivasta.
|
| 264 |
|
1 |
|a Hoboken, N.J. :
|b John Wiley & Sons,
|c [2011]
|
| 264 |
|
4 |
|c ©2011
|
| 300 |
|
|
|a 1 online resource (xiii, 454 pages) :
|b illustrations (some color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 380 |
|
|
|a Bibliography
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Microbial vaccines design : the reverse vaccinology approach /
|r Roberto Rosini, Michele A. Barocchi, Rino Rappuoli --
|t Design and development of recombinant vaccines with viral properties /
|r Gerd Lipowsky, Martin F. Bachmann --
|t Tools for vaccine design : prediction and validation of highly immunogenic and conserved class II epitopes, and development of epitope-driven vaccines /
|r Anne S. De Groot [and others] --
|t Virus like-particle vaccines advantages and challenges /
|r Ted M. Ross [and others] --
|t Design platforms of nanocapsules for human therapeutics or vaccines /
|r Masaaki Kawano [and others] --
|t Designing immunogens for vaccine development in reference to HIV /
|r Aemro Kassa [and others].
|
| 505 |
8 |
0 |
|t Expression and purification of recombinant proteins for vaccine applications /
|r Carlo Zambonelli, Deeann Martinez-Guzmann, and Indresh K. Srivastava --
|t DNA vaccines for infectious diesase /
|r Samuel Stepenson, Manmohan Singh, Indresh K. Srivastava --
|t Developing stable cell lines for the production of vaccine antigens /
|r Xiaotian Zhong [and others] --
|t Spectroscopy of vaccines /
|r C. Russell Middaugh, Sangeeta B. Joshi --
|t Biophysical characterization of protein antigens within vaccine formulations /
|r Padima Malyala, Derek O'Hagan, Manmohan Singh --
|t Structural characteristics predict the stability of HIV /
|r Zohar Biron [and others] --
|t Selection of optimal adjuvants and product factors that affect vaccine immunogenicity /
|r Wei Wang, Manmohan Singh --
|t Lyophilization and stabilization of vaccines /
|r James Chesko [and others] --
|t Effect of buffers and stabilizers on vaccine stability and efficacy /
|r Shireesh P. Apte, Sydney Ugwu --
|t Selection of final product containers /
|r Luis Baez, Adrian Distler --
|t From the lab to the clinic : filing a phase I IND for an investigational vaccine /
|r Kenneth G. Surowitz.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Vaccines.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
|
0 |
|a Drug stability.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Drug development.
|2 fast
|0 (OCoLC)fst00898670
|
| 650 |
|
7 |
|a Drug stability.
|2 fast
|0 (OCoLC)fst00898707
|
| 650 |
|
7 |
|a Vaccines.
|2 fast
|0 (OCoLC)fst01163573
|
| 650 |
|
2 |
|a Vaccines
|x pharmacology.
|
| 650 |
|
2 |
|a Drug Discovery
|x methods.
|
| 650 |
|
2 |
|a Drug Stability.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
0 |
|
|a Manmohan Singh,
|d 1964 November 8-
|
| 700 |
1 |
|
|a Srivasta, Indresh K.
|
| 776 |
0 |
8 |
|i Print version:
|t Development of vaccines.
|d Hoboken, N.J. : John Wiley & Sons, ©2011
|z 9780470256374
|w (DLC) 2010048282
|w (OCoLC)682072290
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118023648
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
